We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CTNM market cap is 371.46M. The company's latest EPS is USD 0.8814 and P/E is 16.35.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD (US$) | |||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -9.93M | -10.94M | -12.97M |
| Net Income | -8.42M | -9.01M | -10.27M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 50M |
| Operating Income | 16.08M |
| Net Income | 22.72M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD (US$) | |||
| Total Assets | 123.56M | 221.36M | 216.03M |
| Total Liabilities | 6.57M | 3.85M | 5.81M |
| Total Equity | -75.63M | 217.5M | 210.23M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 130.39M |
| Total Liabilities | 5.7M |
| Total Equity | -67.94M |
| Market Cap | 371.46M |
| Price to Earnings Ratio | 16.35 |
| Price to Sales Ratio | 7.43 |
| Price to Cash Ratio | 23.92 |
| Price to Book Ratio | 2.98 |
| Dividend Yield | - |
| Shares Outstanding | 25.78M |
| Average Volume (1 week) | 283.94k |
| Average Volume (1 Month) | 131.31k |
| 52 Week Change | -0.62% |
| 52 Week High | 22.00 |
| 52 Week Low | 12.33 |
| Spread (Intraday) | 16.95 (74.64%) |
| Company Name | Contineum Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.contineum-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
